| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $14.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2018 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 15,000 | $69.36 | $1,040,400.00 | -4.7% | |
| Aug 30, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sell | 27,154 | $20.08 | $545,161.54 | -11.1% | |
| Apr 27, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 5,481 | $16.76 | $91,839.15 | -2.0% | |
| Apr 25, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 11,615 | $16.78 | $194,942.20 | -2.8% | |
| Apr 20, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 10,058 | $17.73 | $178,375.51 | -2.4% |